A drug which is said to "reboot" the immune system has been shown to be an effective treatment for multiple sclerosis (MS), a study has found.
The results of the trials were so encouraging in reducing the number of attacks in those affected that the MS Society is campaigning for the drug to become available on the NHS.
The research showed that alemtuzumab significantly reduced the number of attacks or relapses by people with MS compared to the current drug interferon beta-1a which is known commercially as Rebif.
More top news
The world-famous theoretical physicist described the US presidential candidate as a "demagogue" to Good Morning Britain.
Cincinnati Zoo's director stood by the decision to shoot dead a 17-year-old gorilla after a toddler accidentally entered his sanctuary.
A total of 8,648 sailors died during the largest naval engagement during the First World War, which marks its centenary on Tuesday.